Involvement of streptococcal mitogenic exotoxin Z in streptococcal toxic shock syndrome

Journal of Clinical Microbiology

Volumn 43, Issue 7, 2005, Pages 3570-3573

  Yang, Lily ^a   Thomas, Mark ^a   Woodhouse, Andrew ^b   Martin, Diana ^c   Fraser, John D ^a   Proft, Thomas ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b AUCKLAND CITY HOSPITAL   (New Zealand)

^c INSTITUTE OF ENVIRONMENTAL SCIENCE AND RESEARCH   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

CEFUROXIME; ERYTHROMYCIN; EXOTOXIN; PENICILLIN G; STREPTOCOCCAL MITOGENIC EXOTOXIN Z; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BACTERIAL STRAIN; CASE REPORT; CONTROLLED STUDY; FEMALE; GENETIC VARIABILITY; HUMAN; HUMAN CELL; HUMAN TISSUE; MITOGENESIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SEROCONVERSION; STRAIN IDENTIFICATION; STREPTOCOCCUS PYOGENES; STREPTOCOCCUS PYOGENES EMM118; TOXIC SHOCK SYNDROME;

ADULT; ANTIGENS, BACTERIAL; BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIAL TOXINS; CARRIER PROTEINS; EXOTOXINS; FEMALE; HUMANS; MOLECULAR SEQUENCE DATA; SEQUENCE ANALYSIS, DNA; SHOCK, SEPTIC; STREPTOCOCCUS PYOGENES;

STREPTOCOCCUS PYOGENES;

EID: 22144447139     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.43.7.3570-3573.2005     Document Type: Article

References (17)

1. Basma, H., A. Norrby-Teglund, Y. Guedez, A. McGreer, D. E. Low, O. El-Ahmedy, B. Schwartz, and M. Kotb. 1999. Risk factors in the pathogenesis of invasive group A streptococcal infections: role of protective humoral immunity. Infect. Immun. 67:1871-1877.
2. Bonventre, P. F., H. Heeg, C. Cullen, and C. J. Lian. 1993. Toxicity of recombinant toxic shock syndrome toxin 1 and mutant toxins produced by Staphylococcus aureus in a rabbit infection model of toxic shock syndrome. Infect. Immun. 61:793-799.
3. Eriksson, B. K. G., J. Andersson, S. E. Holm, and M. Norgen. 1999. Invasive group A streptococcal infections: T1M1 isolates expressing pyrogenic exotoxins A and B in combination with selective lack of toxin-neutralizing antibodies are associated with increased risk of streptococcal toxic shock syndrome. J. Infect. Dis. 180:410-418.
4. Facklam, R. F., D. R. Martin, M. Lovgren, D. R. Johnson, A. Efstratiou, T. A. Thompson, S. Gowan, P. Kriz, G. J. Tyrell, E. Kaplan, and B. Beall. 2002. Extension of the Lancefield classification for group A streptococci by addition of 22 new M protein gene sequence types from clinical isolates: emm103 to emm124. Clin. Infect. Dis. 34:28-38.
5. Herman, A., J. W. Kappler, P. Marrack, and A. M. Pullen. 1991. Superantigens: mechanism of T-cell stimulation and role in immune responses. Annu. Rev. Immunol. 9:745-772.
6. Kaplan, E. L. 1991. The resurgence of group A streptococcal infections and their sequelae. Eur. J. Clin. Microbiol. Infect. Dis. 10:55-57.
7. McCormick, J. K., J. M. Yarwood, and P. M. Schlievert. 2001. Toxic shock syndrome and bacterial superantigens: an update. Annu. Rev. Microbiol. 55:77-104.
8. Miethke, T., C. Wahl, K. Heeg, B. Echtenacher, P. H. Krammer, and H. Wagner. 1992. T cell-mediated lethal shock triggered in mice by the superantigen staphylococcal enterotoxin B: critical role of tumor necrosis factor. J. Exp. Med. 175:91-98.
9. Muller-Alouf, H., T. Proft, T. M. Zollner, D. Gerlach, E. Champagne, P. Desreumaux, C. Fitting, C. Geoffroy-Fauvet, J. E. Alouf, and J. M. Cavaillon. 2001. Pyrogenicity and cytokine-inducing properties of Streptococcus pyogenes superantigens: comparative study of streptococcal mitogenic exotoxin Z and pyrogenic exotoxin A. Infect. Immun. 69:4141-4145.
10. Proft, T., and J. D. Fraser. 2003. Bacterial superantigens. Clin. Exp. Immunol. 133:299-306.
11. Proft, T., S. L. Moffatt, K. D. Weller, A. Paterson, D. Martin, and J. D. Fraser. 2000. The streptococcal superantigen SMEZ exhibits wide allelic variation, mosaic structure, and significant antigenic variation. J. Exp. Med. 191:1765-1776.
12. Proft, T., S. Sriskandan, L. Yang, and J. D. Fraser. 2003. Superantigens and streptococcal toxic shock syndrome. Emerg. Infect. Dis. 9:1211-1218.
13. Sriskandan, S., D. Moyes, and J. Cohen. 1996. Detection of circulating bacterial superantigen and lymphotoxin-α in patients with streptococcal toxic-shock syndrome. Lancet 348:1315-1316.
14. Stevens, D. L. 2000. Streptococcal toxic shock syndrome associated with necrotizing fasciitis. Annu. Rev. Med. 51:271-288.
15. Stevens, D. L., A. E. Bryant, S. P. Hackett, A. Chang, G. Peer, S. Kosanke, T. Emerson, and L. Hinshaw. 1996. Group A streptococcal bacteremia: the role of tumor necrosis factor in shock and organ failure. J. Infect. Dis. 173:619-626.
16. Talkington, D. F., B. Schwartz, C. M. Black, J. K. Todd, J. Elliott, R. F. Breiman, and R. R. Facklam. 1993. Association of phenotypic and genotypic characteristics of invasive Streptococcus pyogenes isolates with clinical components of streptococcal toxic shock syndrome. Infect. Immun. 61:3369-3374.
17. Unnikrishnan, M., D. M. Altmann, T. Proft, F. Wahid, J. Cohen, J. D. Fraser, and S. Sriskandan. 2002. The bacterial superantigen streptococcal mitogenic exotoxin Z is the major immunoactive agent of Streptococcus pyogenes. J. Immunol. 169:2561-2569.